State Street Corp Lyra Therapeutics, Inc. Transaction History

State Street Corp

$2.47 Trillion
Q4 2024

A detailed history of State Street Corp transactions in Lyra Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 488,720 shares of LYRA stock, worth $97,744. This represents 0.0% of its overall portfolio holdings.

Number of Shares

488,720

Previous 488,720 -0.0%

Holding current value

$97,744

Previous $127,000 19.69%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.24 - $0.34 $54,936 - $77,826	228,900 Added 88.1%	488,720 $127,000
Q2 2024 Aug 14, 2024	BUY	$0.26 - $6.25 $34,746 - $835,250	133,640 Added 105.91%	259,820 $72,000
Q1 2024 May 15, 2024	BUY	$4.55 - $6.53 $77,350 - $111,010	17,000 Added 15.57%	126,180 $784,000
Q4 2023 Feb 14, 2024	BUY	$2.82 - $5.24 $39,762 - $73,884	14,100 Added 14.83%	109,180 $572,000
Q3 2023 Nov 14, 2023	BUY	$2.95 - $4.8 $115,935 - $188,640	39,300 Added 70.46%	95,080 $371,000
Q2 2023 Aug 14, 2023	BUY	$1.98 - $4.33 $36,036 - $78,806	18,200 Added 48.43%	55,780 $229,000
Q4 2022 Feb 14, 2023	BUY	$2.44 - $5.42 $6,190 - $13,750	2,537 Added 7.24%	37,580 $118,000
Q3 2022 Nov 15, 2022	BUY	$4.95 - $6.6 $3,960 - $5,280	800 Added 2.34%	35,043 $176,000
Q2 2022 Aug 15, 2022	BUY	$4.12 - $7.51 $141,081 - $257,164	34,243 New	34,243 $193,000
Q2 2021 Aug 16, 2021	SELL	$6.91 - $12.59 $665,059 - $1.21 Million	-96,246 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$10.38 - $15.61 $193,068 - $290,346	18,600 Added 23.95%	96,246 $1.12 Million
Q4 2020 Feb 16, 2021	BUY	$9.28 - $13.88 $298,259 - $446,103	32,140 Added 70.63%	77,646 $885,000
Q3 2020 Nov 10, 2020	BUY	$10.61 - $13.96 $32,519 - $42,787	3,065 Added 7.22%	45,506 $509,000
Q2 2020 Aug 14, 2020	BUY	$10.91 - $18.56 $463,031 - $787,704	42,441 New	42,441 $481,000

Others Institutions Holding LYRA

# of Institutions

Shares Held

26.2M

Call Options Held

21K

Put Options Held

View Full List

About Lyra Therapeutics, Inc.

Ticker LYRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,826,400
Market Cap $6.37M
Description
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...

More about LYRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Lyra Therapeutics, Inc. Transaction History